VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,922,220 | -35.7% | 525,317 | +68.5% | 0.03% | -32.6% |
| Q2 2023 | $7,649,435 | +9.3% | 311,840 | +3.7% | 0.04% | -8.5% |
| Q1 2023 | $7,000,686 | -10.3% | 300,846 | -2.5% | 0.05% | -27.7% |
| Q4 2022 | $7,806,287 | +30.8% | 308,427 | -0.4% | 0.06% | +1.6% |
| Q3 2022 | $5,969,000 | +41.9% | 309,577 | +87.4% | 0.06% | +64.1% |
| Q2 2022 | $4,207,000 | -33.2% | 165,167 | -32.5% | 0.04% | +5.4% |
| Q1 2022 | $6,297,000 | +24.3% | 244,837 | +102.4% | 0.04% | +37.0% |
| Q4 2021 | $5,064,000 | +93.1% | 120,941 | +100.7% | 0.03% | +50.0% |
| Q3 2021 | $2,623,000 | -3.2% | 60,267 | +5.2% | 0.02% | +5.9% |
| Q2 2021 | $2,709,000 | -74.6% | 57,294 | -72.5% | 0.02% | -76.7% |
| Q1 2021 | $10,677,000 | +697.4% | 208,260 | +316.7% | 0.07% | +461.5% |
| Q4 2020 | $1,339,000 | – | 49,983 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |